Chung A - Search Results

1

Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study.

Badros AZ, Foster L, Anderson LD Jr, Chaulagain CP, Pettijohn EM, Cowan AJ, Costello CL, Larson S, Sborov DW, Shain KH, Silbermann R, Shah N, Chung A, Krevvata M, Pei H, Patel S, Khare V, Cortoos A, Carson R, Lin T, Voorhees PM. Badros AZ, et al. Among authors: chung a. Blood. 2024 Sep 27:blood.2024025746. doi: 10.1182/blood.2024025746. Online ahead of print. Blood. 2024. PMID: 39331724 Free article.

2

Predictors of lenalidomide maintenance duration after autologous stem cell transplant in patients with multiple myeloma.

Rath C, Yoo C, Cheplowitz H, Lo M, Young R, Guglielmo J, Saunders IM, Banerjee R, Young R, Kumar A, Chung A, Rosenberg AS, Costello C, Fine J, Wilson M, Patel N, Banez MT. Rath C, et al. Among authors: chung a. J Oncol Pharm Pract. 2023 Oct;29(7):1715-1724. doi: 10.1177/10781552221150935. Epub 2023 Feb 2. J Oncol Pharm Pract. 2023. PMID: 36731514

3

Daratumumab Plus Bortezomib and Dexamethasone in Newly Diagnosed Systemic Light Chain Amyloidosis.

Kennedy VE, Natsuhara K, Maringanti SA, Shah ND, Arora S, Wolf J, Martin TG, Aras MA, Chung A, Wong SW. Kennedy VE, et al. Among authors: chung a. Curr Probl Cancer. 2023 Jun;47(3):100953. doi: 10.1016/j.currproblcancer.2023.100953. Epub 2023 Feb 14. Curr Probl Cancer. 2023. PMID: 36807996

4

Cytomegalovirus seropositivity is associated with improved responses to CD38 monoclonal antibody therapies in multiple myeloma: A single-centre retrospective study.

Ge AY, Huang CY, Banerjee R, Knoche J, Chung A, Arora S, Martin TG, Wolf J, Wong SW, Wiita AP, Shah N. Ge AY, et al. Among authors: chung a. Br J Haematol. 2023 Jun;201(5):935-939. doi: 10.1111/bjh.18711. Epub 2023 Feb 27. Br J Haematol. 2023. PMID: 36846905

5

Safety and Efficacy of BCMA CAR-T Cell Therapy in Older Patients With Multiple Myeloma.

Reyes KR, Huang CY, Lo M, Arora S, Chung A, Wong SW, Wolf J, Olin RL, Martin T, Shah N, Banerjee R. Reyes KR, et al. Among authors: chung a. Transplant Cell Ther. 2023 Jun;29(6):350-355. doi: 10.1016/j.jtct.2023.03.012. Epub 2023 Mar 17. Transplant Cell Ther. 2023. PMID: 36933659 Free article.

6

Significance of the pee-value: relevance of 24-hour urine studies for patients with myeloma.

Natsuhara KH, Huang CY, Knoche J, Arora S, Chung A, Martin T, Wolf J, Wong SW, Shah N, Banerjee R. Natsuhara KH, et al. Among authors: chung a. Leuk Lymphoma. 2023 Jun;64(6):1186-1193. doi: 10.1080/10428194.2023.2201365. Epub 2023 Apr 25. Leuk Lymphoma. 2023. PMID: 37096638

7

Intensity of Cyclophosphamide-Based Bridging Therapy Before Chimeric Antigen Receptor T Cell Therapy in Myeloma.

Zafar A, Huang CY, Lo M, Arora S, Chung A, Wong SW, Wolf J, Martin TG, Shah N, Banerjee R. Zafar A, et al. Among authors: chung a. Transplant Cell Ther. 2023 Aug;29(8):504.e1-504.e7. doi: 10.1016/j.jtct.2023.05.016. Epub 2023 May 26. Transplant Cell Ther. 2023. PMID: 37244643 Free article.

8

Impact of corticosteroids on efficacy of BCMA targeted CAR-T therapy in multiple myeloma.

Duvalyan E, Shah N, Lo M, Martin T 3rd, Wolf JL, Chung A, Arora S, Huang CY, Wong SW. Duvalyan E, et al. Among authors: chung a. Leuk Lymphoma. 2023 Nov-Dec;64(11):1888-1891. doi: 10.1080/10428194.2023.2240920. Epub 2023 Aug 21. Leuk Lymphoma. 2023. PMID: 37599633 No abstract available.

9

Salvage therapies including retreatment with BCMA-directed approaches after BCMA CAR-T relapses for multiple myeloma.

Reyes KR, Liu YC, Huang CY, Banerjee R, Martin T, Wong SW, Wolf JL, Arora S, Shah N, Chari A, Chung A. Reyes KR, et al. Among authors: chung a. Blood Adv. 2024 May 14;8(9):2207-2216. doi: 10.1182/bloodadvances.2023012066. Blood Adv. 2024. PMID: 38429087 Free PMC article.

10

Measurable residual disease (MRD) dynamics in multiple myeloma and the influence of clonal diversity analyzed by artificial intelligence.

Martinez-Lopez J, Lopez-Muñoz N, Chari A, Dorado S, Barrio S, Arora S, Kumar A, Chung A, Martin T, Wolf J. Martinez-Lopez J, et al. Among authors: chung a. Blood Cancer J. 2024 Aug 7;14(1):131. doi: 10.1038/s41408-024-01102-x. Blood Cancer J. 2024. PMID: 39112458 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,956 results

Search Page

Filters